A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality